GeneTex Inc

The company's initial focus was concentrated on a portfolio of reagents that met the needs of researchers working to solve the puzzle of what causes cancer and how cancer can be better diagnosed, More recently, tools for scientists studying basic mechanisms common to many forms of cancer have been added. These research tools include immunological reagents such as Ab Combo Pack which is an NFkB antibody panel with control peptides for ELISAsupershift assay applications and AKT peptides targeting the Protein Kinase B

Further Information: http://www.genetex.com/